India

Possible Game Changer: Bharat Biotech’s Nasal Vaccine Against COVID-19 Cleared For Use

By
OB Bureau

New Delhi: In a major boost to India, Bharat Biotech’s first-of-its-kind needle-free intranasal vaccine for COVID-19 received emergency use authorisation from the Drugs Controller General of India (DCGI) on Tuesday. The regulator approved the vaccine for primary immunisation of those aged 18 years and above, for restricted use in emergency situations, Union health minister Mansukh Mandaviya tweeted.

According to Bharat Biotech, its COVID-19 intranasal vaccine, BBV154, has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials phase III. The vaccine candidate was evaluated earlier in phase I and II clinical trials with successful results. Bharat Biotech chairman and managing director Krishna Ella had recently said that the firm completed clinical trials of the nasal vaccine with about 4,000 volunteers and there is no single instance of side effect or adverse reaction reported so far, News18 reported.

Bharat Biotech’s nasal vaccine uses a chimpanzee cold virus to deliver a harmless copy of the coronavirus spike protein to the lining of the nose. It has been specifically formulated to allow intranasal delivery and has been developed in partnership with Washington University St Louis, which had designed and developed the recombinant adenoviral vectored constructs and evaluated them in preclinical studies for efficacy.

The DCGI had earlier given its nod to conduct clinical trials for Bharat Biotech’s intranasal vaccine as a booster dose. The drug regulator had also permitted the firm to conduct a phase 3 clinical trial to compare the immunogenicity and safety of BBV154 (intranasal) with Covaxin.

Two separate and simultaneous clinical trials were conducted to evaluate BBV154 as a primary dose (2-dose) schedule and a heterologous booster dose for subjects who have previously received two doses of the two commonly administered COVID vaccines in India.

OB Bureau

Recent Posts

Odisha CM Directs To Supply 3 Months’ PDS Rice To Beneficiaries In Advance

Bhubaneswar: Odisha Chief Minister on Tuesday issued direction to provide rice of three months' quota…

November 5, 2024

[Watch] Salman Khan Shoots For ‘Sikander’ In Falaknuma Palace Amid Tight Security

Mumbai: In the wake of a fresh death threat by the Lawrence Bishnoi gang, actor…

November 5, 2024

Bachchan Family Upset With Nimrat Kaur, To Take Action Against Source Of Rumour

Mumbai: Rumours about Abhishek Bachchan and Aishwarya Rai’s divorce have been doing the rounds for…

November 5, 2024

Surge In Patients With Respiratory Issues In Delhi Hospitals

New Delhi: Hospitals across Delhi are witnessing a spike in the number of patients with…

November 5, 2024

ISKCON Cancels ‘Untimely’ Rath Yatra In Houston

Bhubaneswar: Facing a strong opposition from the devotees of Lord Jagannath and Puri Gajapati Maharaja…

November 5, 2024

[Watch] Is Abhishek Bachchan’s ‘I Want To Talk’ Similar To Dad Amitabh’s ‘Piku’?

Mumbai: The trailer of the highly-anticipated Abhishek Bachchan starrer ‘I Want to Talk’ was unveiled…

November 5, 2024

One Killed, Two Injured In Mukhyamantri Bus-Bike Collision In Odisha’s Ganjam

Berhampur: One person was killed and two others were injured in a collision between a…

November 5, 2024

Raveena Tandon’s Daughter To Debut With Ajay Devgn’s Nephew

Mumbai: Bollywood actress Raveena Tandon’s beautiful daughter Rasha Thadani is all set to make her…

November 5, 2024